NewsEvents

Your Yourlocation: Home > Capsule combined with tiotropium bromide(136310-93-5) in the treatment of patients with stable COPD

To investigate the clinical efficacy of Yifei capsule combined with tiotropium bromide(136310-93-5) in the treatment of chronic obstructive pulmonary disease (COPD). Long-term use of Yifei capsule combined with tiotropium inhalation in COPD patients with type C and D can significantly improve lung function, improve exercise tolerance, improve arterial blood gas index, delay disease progression and improve quality of life. The article published on 2015 06 "Practical Clinical Integrative Medicine".

86 patients with stable COPD were randomly divided into control group and observation group (43 cases). The control group was treated with short-acting bronchodilator and long-term home oxygen therapy, and tiotropium bromide(136310-93-5) inhaler (18μg / (1 g / d), the treatment group was treated with Yifei capsule (1.2 g, 3 times / d) on the basis of the control group, the course of treatment was 6 months. The changes of lung function, exercise tolerance, dyspnea score and blood gas analysis were observed before and after treatment.

The pulmonary function index, 6-minute walking distance (6MWD) and arterial oxygen pressure (PO2) of the two groups were significantly increased after treatment. After treatment, the scores of dyspnea score (Mmrc), arterial partial pressure of carbon dioxide (PCO2) (P <0.05) .Conclusion: The treatment group is better than the control group (P <0.05).

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved